Display options
Share it on

Curr Oncol. 2016 Jun;23(3):e276-9. doi: 10.3747/co.23.2394. Epub 2016 Jun 09.

Can the referring surgeon enhance accrual of breast cancer patients to medical and radiation oncology trials? The ENHANCE study.

Current oncology (Toronto, Ont.)

A Arnaout, I Kuchuk, N Bouganim, G Pond, S Verma, R Segal, S Dent, S Gertler, X Song, F Kanji, M Clemons

Affiliations

  1. Division of Surgical Oncology, Department of Surgery, Ottawa General Hospital, and University of Ottawa, Ottawa, ON;
  2. Division of Medical Oncology, Department of Medicine, Ottawa General Hospital, and University of Ottawa, Ottawa, ON;
  3. Division of Medical Oncology, Segal Cancer Centre, and Jewish General Hospital, Montreal, QC;
  4. Department of Oncology, McMaster University, Hamilton, ON;
  5. Clinical Trials Department, Ottawa Hospital Research Institute, Ottawa, ON.

PMID: 27330365 PMCID: PMC4900848 DOI: 10.3747/co.23.2394

Abstract

INTRODUCTION: The accrual rate to clinical trials in oncology remains low. In this exploratory pilot study, we prospectively assessed the role that engaging a referring surgeon plays in enhancing nonsurgical oncologic clinical trial accrual.

METHODS: Newly diagnosed breast cancer patients were seen by a surgeon who actively introduced specific patient-and physician-centred strategies to increase clinical trial accrual. Patient-centred strategies included providing patients, before their oncology appointment, with information about specific clinical trials for which they might be eligible, as evaluated by the surgeon. The attitudes of the patients about clinical trials and the interventions used to improve accrual were assessed at the end of the study. The primary outcome was the clinical trial accrual rate during the study period.

RESULTS: Overall clinical trial enrolment during the study period among the 34 participating patients was 15% (5 of 34), which is greater than the institution's historical average of 7%. All patients found the information delivered by the surgeon before the oncology appointment to be very helpful. Almost three quarters of the patients (73%) were informed about clinical trials by their oncologist. The top reasons for nonparticipation reported by the patients who did not participate in clinical trials included lack of interest (35%), failure of the oncologist to mention clinical trials (33%), and inconvenience (19%).

CONCLUSIONS: Accrual of patients to clinical trials is a complex multistep process with multiple potential barriers. The findings of this exploratory pilot study demonstrate a potential role for the referring surgeon in enhancing nonsurgical clinical trial accrual.

Keywords: Clinical trials; accrual strategies

References

  1. J Clin Oncol. 2003 Jun 15;21(12):2268-75 - PubMed
  2. Breast. 2005 Aug;14(4):310-6 - PubMed
  3. Tex Med. 2004 Apr;100(4):66-72 - PubMed
  4. J Cancer Educ. 2004 Spring;19(1):58-65 - PubMed
  5. Lancet Oncol. 2006 Feb;7(2):141-8 - PubMed
  6. J Clin Oncol. 2008 May 20;26(15):2562-7 - PubMed
  7. J Clin Oncol. 2001 Mar 15;19(6):1728-33 - PubMed
  8. J Clin Oncol. 2000 Mar;18(6):1203-11 - PubMed
  9. Contemp Clin Trials. 2009 Nov;30(6):552-9 - PubMed
  10. J Clin Oncol. 2003 Mar 1;21(5):830-5 - PubMed
  11. J Clin Oncol. 2008 Sep 20;26(27):4458-65 - PubMed
  12. Gynecol Oncol. 2010 Mar;116(3):295-300 - PubMed
  13. Appl Nurs Res. 2013 Aug;26(3):133-5 - PubMed
  14. Mayo Clin Proc. 2009 Mar;84(3):243-7 - PubMed

Publication Types